When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn advancing mid-stage study of PRO 140 for COVID-19
CytoDyn Inc
Base on FDA feedback, CytoDyn (OTCQB:CYDY-1%) has filed a modified IND and protocol with the agency for a Phase 2 clinical trial evaluating lead drug leronlimab (PRO 140) in COVID-19 patients experiencing respiratory complications.
More news on: CytoDyn Inc., Healthcare stocks news,